DEXTRON INJECTABLE GLUCOSE SOLUTION Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dextron injectable glucose solution

nutrien ag solutions limited - glucose - parenteral liquid/solution/suspension - glucose carbohydrate active 400.0 g/l - nutrition & metabolism - cattle | sheep pregnant | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer - ketosis | mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | elevated ketones | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | non-clinical ketosis | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies

Glucose 5% Freeflex (Fresenius) Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glucose 5% freeflex (fresenius)

fresenius kabi new zealand limited - glucose monohydrate 55 g/l;   - solution for infusion - 5 % - active: glucose monohydrate 55 g/l   excipient: hydrochloric acid sodium hydroxide water for injection

Glucose Injection (Baxter) Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 5% - solution for infusion - 5 % - active: glucose monohydrate 5% - isotonic (glucose 5%) infusion solutions are mainly indicated for: - whenever non-electrolyte fluid replacement is required, - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

Sodium Iodide (I131) Capsule T 37-7400 MBq hard capsule Irlanda - inglês - HPRA (Health Products Regulatory Authority)

sodium iodide (i131) capsule t 37-7400 mbq hard capsule

curium netherlands b.v. - sodium iodide (131 i) - capsule, hard - 37-7400 megabecquerel(s) - iodine (131i) compounds; sodium iodide (131i)

PREPOPIK- sodium picosulfate, magnesium oxide, and anhydrous citric acid powder, metered Estados Unidos - inglês - NLM (National Library of Medicine)

prepopik- sodium picosulfate, magnesium oxide, and anhydrous citric acid powder, metered

ferring pharmaceuticals inc. - sodium picosulfate (unii: lr57574hn8) (deacetylbisacodyl - unii:r09078e41y), magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium picosulfate 10 mg in 16.1 g - prepopik® is indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients 9 years of age and older. prepopik is contraindicated in the following conditions: - patients with severe renal impairment (creatinine clearance less than 30 ml/minute) which may result in accumulation of magnesium [see warnings and precautions (5.4)] - gastrointestinal obstruction or ileus [see warnings and precautions (5.6)] - bowel perforation [see warnings and precautions (5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any of the ingredients in prepopik [see adverse reactions (6.2)] risk summary there are no data with prepopik use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in an animal reproduction study, no adverse developmental effects were observed in pregnant rats when sodium picosulfate, magnesium oxide, and anhydrous citric acid were administered orally at doses 1

PHEBRA GLUCOSE 50% intravenous infusion 25g/50mL vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

phebra glucose 50% intravenous infusion 25g/50ml vial

phebra pty ltd - glucose, quantity: 500 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections; sodium bicarbonate - glucose 50% intravenous infusion is strongly hypertonic and may be used to reduce increased cerebrospinal pressure and/or oedema due to delirium tremens or acute alcoholic intoxication. it may also be used to treat severe hypoglycaemia due to an excess of insulin and to provide concentrated calories in total parenteral nutrition regimes.

Glucose 5 % B. Braun Mini-Plasco inj. sol. i.v. amp. Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glucose 5 % b. braun mini-plasco inj. sol. i.v. amp.

b. braun melsungen ag - glucose monohydrate 55 mg/ml - eq. glucose anhydrous 50 g/l - solution for injection - glucose monohydrate 55 mg/ml - glucose

Glucose 30 % inf. sol. i.v. vial Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glucose 30 % inf. sol. i.v. vial

dechra veterinary products sa-nv - glucose monohydrate - eq. dextrose anhydrous 300 mg/ml - solution for infusion - 30 % - glucose monohydrate - glucose - cattle; goat; sheep

Glucose 30 % Kela inf. sol. i.v. Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glucose 30 % kela inf. sol. i.v.

kela laboratoria sa-nv - glucose monohydrate 330 mg/ml - eq. glucose anhydrous 300 mg/ml - solution for infusion - glucose monohydrate 330 mg/ml - glucose - cattle

Glucose 5 g/100 ml B. Braun Vet Care inf. sol. i.v. vial Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glucose 5 g/100 ml b. braun vet care inf. sol. i.v. vial

b. braun melsungen ag - glucose monohydrate 55 mg/ml - eq. glucose anhydrous 50 g/l - solution for infusion - glucose monohydrate 55 mg/ml - glucose - cattle; dog; goat; horse; cat; sheep; pig